Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome

Background: The concurrence of metabolic syndrome (MS) and diabetes mellitus (DM) is increasing worldwide. The long-term complications of these chronic diseases are a threat to patients' well-being. Oxidative stress is involved in the pathogenesis of several diseases. To understand the basic pa...

Full description

Bibliographic Details
Main Authors: Ali Najafi, Morteza Pourfarzam, Fouzieh Zadhoush
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=6;epage=6;aulast=Najafi
id doaj-454fe902cff64a57bef50ad288707b68
record_format Article
spelling doaj-454fe902cff64a57bef50ad288707b682021-03-31T07:29:48ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362021-01-012616610.4103/jrms.JRMS_249_20Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndromeAli NajafiMorteza PourfarzamFouzieh ZadhoushBackground: The concurrence of metabolic syndrome (MS) and diabetes mellitus (DM) is increasing worldwide. The long-term complications of these chronic diseases are a threat to patients' well-being. Oxidative stress is involved in the pathogenesis of several diseases. To understand the basic pathophysiological mechanisms of Type-2 DM (T2DM) and its related complications, we aimed to investigate the oxidant/antioxidant status and Na+-K+ ATPase activity in T2DM with MS. Materials and Methods: A population of ninety individuals including fifty patients diagnosed with T2DM and MS, but without overt diabetes complications, and forty individuals without T2DM or MS as control group participated in this study. Plasma malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx) activities, total antioxidant capacity (TAC), and Na+-K+ ATPase activity were assessed by standard laboratory methods. Results: Plasma MDA in patients group was statistically significantly higher than that of controls (P ≤ 0.05). Whereas, Na+-K+ ATPase activity was statistically significantly lower in patient group (P ≤ 0.05). TAC, CAT, SOD, and GPx enzyme activities were not statistically significantly different between two groups (P > 0.05). Results from the patient group showed positive correlations between CAT activity and triglyceride and positive correlations between GPx activity and weight, body mass index (BMI), and waist circumference. In addition, there was a positive correlation between MDA results with high-density lipoprotein-cholesterol (HDL-C) and total cholesterol and a negative correlation with TAC, BMI, and weight (P ≤ 0.05) in controls. Conclusion: Because T2DM patients were without any vascular complications, antioxidant defense results may reflect the lack of progression of diabetes complications in these patients. These results emphasize the need for initial and continued assessment of cardiovascular disease risks in diabetic individuals. Implementation of timely interventions may improve the management of diabetes and prevent the progression of diabetes complications.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=6;epage=6;aulast=Najafidiabetes mellitus type 2metabolic syndromeoxidative stresssodium-potassium-exchanging atpase
collection DOAJ
language English
format Article
sources DOAJ
author Ali Najafi
Morteza Pourfarzam
Fouzieh Zadhoush
spellingShingle Ali Najafi
Morteza Pourfarzam
Fouzieh Zadhoush
Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome
Journal of Research in Medical Sciences
diabetes mellitus type 2
metabolic syndrome
oxidative stress
sodium-potassium-exchanging atpase
author_facet Ali Najafi
Morteza Pourfarzam
Fouzieh Zadhoush
author_sort Ali Najafi
title Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome
title_short Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome
title_full Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome
title_fullStr Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome
title_full_unstemmed Oxidant/antioxidant status in Type-2 diabetes mellitus patients with metabolic syndrome
title_sort oxidant/antioxidant status in type-2 diabetes mellitus patients with metabolic syndrome
publisher Wolters Kluwer Medknow Publications
series Journal of Research in Medical Sciences
issn 1735-1995
1735-7136
publishDate 2021-01-01
description Background: The concurrence of metabolic syndrome (MS) and diabetes mellitus (DM) is increasing worldwide. The long-term complications of these chronic diseases are a threat to patients' well-being. Oxidative stress is involved in the pathogenesis of several diseases. To understand the basic pathophysiological mechanisms of Type-2 DM (T2DM) and its related complications, we aimed to investigate the oxidant/antioxidant status and Na+-K+ ATPase activity in T2DM with MS. Materials and Methods: A population of ninety individuals including fifty patients diagnosed with T2DM and MS, but without overt diabetes complications, and forty individuals without T2DM or MS as control group participated in this study. Plasma malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx) activities, total antioxidant capacity (TAC), and Na+-K+ ATPase activity were assessed by standard laboratory methods. Results: Plasma MDA in patients group was statistically significantly higher than that of controls (P ≤ 0.05). Whereas, Na+-K+ ATPase activity was statistically significantly lower in patient group (P ≤ 0.05). TAC, CAT, SOD, and GPx enzyme activities were not statistically significantly different between two groups (P > 0.05). Results from the patient group showed positive correlations between CAT activity and triglyceride and positive correlations between GPx activity and weight, body mass index (BMI), and waist circumference. In addition, there was a positive correlation between MDA results with high-density lipoprotein-cholesterol (HDL-C) and total cholesterol and a negative correlation with TAC, BMI, and weight (P ≤ 0.05) in controls. Conclusion: Because T2DM patients were without any vascular complications, antioxidant defense results may reflect the lack of progression of diabetes complications in these patients. These results emphasize the need for initial and continued assessment of cardiovascular disease risks in diabetic individuals. Implementation of timely interventions may improve the management of diabetes and prevent the progression of diabetes complications.
topic diabetes mellitus type 2
metabolic syndrome
oxidative stress
sodium-potassium-exchanging atpase
url http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2021;volume=26;issue=1;spage=6;epage=6;aulast=Najafi
work_keys_str_mv AT alinajafi oxidantantioxidantstatusintype2diabetesmellituspatientswithmetabolicsyndrome
AT mortezapourfarzam oxidantantioxidantstatusintype2diabetesmellituspatientswithmetabolicsyndrome
AT fouziehzadhoush oxidantantioxidantstatusintype2diabetesmellituspatientswithmetabolicsyndrome
_version_ 1724177885469605888